These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8551701)
1. [Role of glycosaminoglycans relating to formation of urolithiasis]. Nishio S Nihon Hinyokika Gakkai Zasshi; 1995 Nov; 86(11):1597-609. PubMed ID: 8551701 [No Abstract] [Full Text] [Related]
2. Analysis of glycosaminoglycans induced in newly formed calcium oxalate crystals using an undiluted urine system. Suzuki K; Tsugawa R Scanning Microsc; 1995; 9(4):1089-95; discussion 1095-6. PubMed ID: 8819890 [TBL] [Abstract][Full Text] [Related]
3. Is there a role for pentosan polysulfate in the prevention of calcium oxalate stones? Jones M; Monga M J Endourol; 2003 Dec; 17(10):855-8. PubMed ID: 14744348 [TBL] [Abstract][Full Text] [Related]
4. [Studies on urolithiasis. The histochemistry of the kidney tissues and stones from patients with urolithiasis]. Tsai S Hinyokika Kiyo; 1986 Jan; 32(1):27-42. PubMed ID: 2938457 [TBL] [Abstract][Full Text] [Related]
5. Glycosaminoglycans and other sulphated polysaccharides in calculogenesis of urinary stones. Boevé ER; Cao LC; Verkoelen CF; Romijn JC; de Bruijn WC; Schröder FH World J Urol; 1994; 12(1):43-8. PubMed ID: 8012415 [TBL] [Abstract][Full Text] [Related]
6. [Glycoproteins, glycosaminoglycans, and urolithiasis]. Grases F; Costa-Bauzá A; Llobera A Med Clin (Barc); 1995 Jun; 105(1):31-5. PubMed ID: 7637413 [No Abstract] [Full Text] [Related]
7. In vitro studies on the role of glycosaminoglycans in crystallization intensity during infectious urinary stones formation. Torzewska A; Różalski A APMIS; 2014 Jun; 122(6):505-11. PubMed ID: 24164670 [TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans as inhibitors of stone formation. Sallis JD Miner Electrolyte Metab; 1987; 13(4):273-7. PubMed ID: 3306320 [TBL] [Abstract][Full Text] [Related]
9. Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route. Dawes J; Pepper DS Thromb Haemost; 1992 Apr; 67(4):468-72. PubMed ID: 1378652 [TBL] [Abstract][Full Text] [Related]
10. [A study of crystallization on urolithiasis in vitro]. Miyazawa K; Suzuki K; Tsugawa R Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765 [TBL] [Abstract][Full Text] [Related]
11. Sodium pentosan polysulphate--a novel inhibitor of urinary risk factors and enzymes in experimental urolithiatic rats. Senthil D; Malini MM; Varalakshmi P Ren Fail; 1998 Jul; 20(4):573-80. PubMed ID: 9713875 [TBL] [Abstract][Full Text] [Related]
12. [Significance of kidney mucopolysaccharides in the pathogenesis of urolithiasis]. Kiseleva AF; Blagodarov VN Vrach Delo; 1973 Jul; 7(7):49-52. PubMed ID: 4271164 [No Abstract] [Full Text] [Related]
14. The etiology and control of urolithiasis. Udall RH; Chow FH Adv Vet Sci Comp Med; 1969; 13():29-57. PubMed ID: 4309744 [No Abstract] [Full Text] [Related]
15. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones. Sallis JD; Lumley MF Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124 [TBL] [Abstract][Full Text] [Related]
17. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis. Gohel MD; Shum DK; Tam PC Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044 [TBL] [Abstract][Full Text] [Related]